# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
According to data from Benzinga Pro, during Q2, Brickell Biotech's (NASDAQ:BBI) reported sales totaled $4.32 million. Despi...
https://twitter.com/PatentGrants/status/1565734028765892610
- Reuters
Brickell Biotech (NASDAQ:BBI) reported quarterly losses of $(0.01) per share. This is a 93.75 percent increase over losses of $...
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per s...
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average vo...